Pay in installments of $6.26 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
For Your Every Summer RSVP, with Code: SUMMER15
Description
Which drug targets will drive the obesity market for the next decade? Pharmaceutical Technology Ozempic and GLP 1: The New Obesity Drug Boom FULL DOCUMENTARY 1 in 8 Americans have taken drugs like Ozempic but mostly not for weight loss GLP 1 Microdosing and Custom Dosing Town & Country Compounding GLP 1 receptor agonists causing euglycemic ketoacidosis in patients without diabetes: a brief review International Journal of Obesity
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.2 ★★★★★
Based on 24 reviews
Sort
Product Reviews
★★★★★ 4
Reading this book is uplifting
Format: Paperback
Great book
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 23, 2017
★★★★★ 5
Amazing book!
Format: Paperback
I love every chapter. It has raised my abilities in using data science, allowing me to demystify data more thoroughly!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 8, 2026
★★★★★ 5
Awesome Book
Format: Paperback
Very useful book. It was exactly what I was looking for.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 8, 2025
★★★★★ 5
Just what I was looking for
Format: Paperback
Good
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 17, 2025
★★★★★ 4
Figures are wrong in the Kindle version
Format: Kindle
Through Chapter 11 so far and the Figures are frequently very wrong. There seem to be a couple other minor errors, but this desperately needs an update for the Kindle version. Content otherwise seems good so far, so hope this gets fixed.
Update: Just after I entered this, the figures seem to have been updated. Checked 4 and all are fixed, so moved the rating up one and will update when through all chapters.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 22, 2023
recommand products
GLP-1 and Anesthesia: Considerations and Cautions for CRNAs
23.00
GLP-1 Agonists - What is it?
20.82
Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review
24.81
Miami Weight Loss Clinic | Affordable GLP-1 Programs & Pricing
26.63
Understanding semaglutide (GLP-1 RA): Are they the right choice for weight loss?
27.24